Novo Nordisk launches Wegovy in India, targets obesity treatment...

Dununu.com Dununu

Patrocinado

Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection

RSS Feed Business

Postado

48

Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks. Priced between Rs 17,345 and Rs 26,050 per month, the injectable drug targets India's large obese population. The company aims to create awareness and collaborate with stakeholders to combat obesity, citing its significant impact on India's GDP.

Read Full Article

Faça o login para curtir, compartilhar e comentar!

'Pushed into deep sea, but he’ll swim'- Gambhir on Gill’s first Test as captain

Gautam Gambhir has urged critics to give Shubman Gill time to prove himself as India's Test...

Por 0 3

White House disputes intelligence report downplaying impact of Iran nuclear strikes

WASHINGTON DC: The White House has rejected a leaked U.S. intelligence assessment suggesting that...

Por 0 8

Our forces brought Pakistan to its knees in 22 minutes, says PM Modi

Por 0 11

For 2 decades, suicide among top 2 causes of death of young Indians

Por 0 11

Widespread rain likely across hilly regions today

KATHMANDU: As monsoon conditions persist across Nepal, the Department of Hydrology and...

Por 0 20